Mechanisms of Carcinogenesis

致癌机制

基本信息

  • 批准号:
    7390356
  • 负责人:
  • 金额:
    $ 24.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-06-24 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Exposure to ultraviolet light, in particular, ultraviolet light B (UVB, ultraviolet light in the wavelengths ranging from 290-320 nm) is known to be a major causative factor in the development of skin cancer. Epidermal cells express a variety of protective molecules that function by absorbing UVB light. Sun exposed tissue is also protected by detoxification and repair enzymes, as well as other antioxidant molecules. The precise mechanisms by which ultraviolet light induces tissue damage are not clear. It has been suggested that cytotoxic reactive oxygen intermediates generated by UVB light in the skin are responsible for causing DNA damage leading to cancer. We have discovered that UVB light rapidly stimulates the production of hydroperoxides by mouse and human keratinocytes in a process that does not require intact cells. Greater amounts of hydroperoxides are produced in calcium-differentiated keratinocytes when compared to growing keratinocytes. Purification studies using homogenates of keratinocytes identified a major protein responsible for generating hydrogen peroxide in the cells in response to UVB light. This UVB light/peroxide generating activity of requires oxygen and is eliminated by heat denaturation. Unexpectedly, sequence analysis identified this protein as catalase, an enzyme known to be responsible for the degradation of intracellular hydrogen peroxide. It is well recognized that catalase also possesses peroxidatic activity and UVB light stimulates this function of the enzyme. In this regard, we found that inhibition of the hydrogen peroxide metabolizing activity of catalase with 3-amino-1,2, 4-triazole or azide markedly enhanced the ability of UVB light to generate hydroperoxides. We hypothesize that catalase is an important mediator of UVB light-induced oxidative stress and DNA damage in keratinocytes. Our specific aims are to determine if catalase mediates ultraviolet light-induced oxidative stress and DNA damage in growing and differentiated keratinocytes and to evaluate the role of the enzyme in UVB-induced carcinogenesis using the mouse skin model. Our proposed studies will provide information on the mechanisms by which ultraviolet light induces DNA damage in the skin and should also provide information on the potential role of catalase in ultraviolet light induced skin cancer.
描述(申请人提供):暴露在紫外线下,特别是紫外线B(UVB,波长在290-320纳米之间的紫外线)是已知的皮肤癌发展的主要诱因。表皮细胞表达多种保护分子,通过吸收UVB光发挥作用。暴露在阳光下的组织也受到解毒和修复酶以及其他抗氧化剂分子的保护。紫外线导致组织损伤的确切机制尚不清楚。有研究表明,紫外线在皮肤中产生的细胞毒性活性氧中间体是导致DNA损伤并导致癌症的原因。我们已经发现,UVB光可以快速刺激小鼠和人类角质形成细胞产生过氧化氢,这一过程不需要完整的细胞。与生长中的角质形成细胞相比,钙化角质形成细胞产生更多的过氧化氢。利用角质形成细胞匀浆进行的纯化研究发现,一种主要蛋白质负责在细胞中产生过氧化氢,以响应UVB光。的这种UVB光/过氧化氢产生活性需要氧气,并通过热变性消除。出乎意料的是,序列分析确定这个蛋白质是过氧化氢酶,一种已知负责降解细胞内过氧化氢的酶。众所周知,过氧化氢酶也具有过氧化活性,而UVB光可以刺激该酶的这一功能。在这方面,我们发现用3-氨基-1,2,4-三氮唑或叠氮抑制过氧化氢酶的代谢活性显著增强了UVB光产生过氧化氢的能力。我们推测,过氧化氢酶是UVB光诱导的氧化应激和角质形成细胞DNA损伤的重要中介。我们的具体目标是确定过氧化氢酶是否介导紫外线诱导的生长和分化角质形成细胞的氧化应激和DNA损伤,并使用小鼠皮肤模型评估过氧化氢酶在紫外线诱导的致癌中的作用。我们提出的研究将提供关于紫外线诱导皮肤DNA损伤的机制的信息,也应该提供关于过氧化氢酶在紫外线诱导皮肤癌中的潜在作用的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIANE E HECK其他文献

DIANE E HECK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIANE E HECK', 18)}}的其他基金

Pharmacology and Pre-Clinical Toxicology
药理学和临床前毒理学
  • 批准号:
    7933779
  • 财政年份:
    2009
  • 资助金额:
    $ 24.03万
  • 项目类别:
Pharmacology and Pre-Clinical Toxicology
药理学和临床前毒理学
  • 批准号:
    7653734
  • 财政年份:
    2008
  • 资助金额:
    $ 24.03万
  • 项目类别:
CHEMICAL AND ENVIRONMENTAL EFFECTS ON MAMMALIAN SKIN
化学和环境对哺乳动物皮肤的影响
  • 批准号:
    7721111
  • 财政年份:
    2007
  • 资助金额:
    $ 24.03万
  • 项目类别:
Pharmacology and drug development
药理学和药物开发
  • 批准号:
    7468062
  • 财政年份:
    2007
  • 资助金额:
    $ 24.03万
  • 项目类别:
CONTROL OF MITOCHONDRIAL FUNCTION BY NITRIC OXIDE
一氧化氮对线粒体功能的控制
  • 批准号:
    7721071
  • 财政年份:
    2007
  • 资助金额:
    $ 24.03万
  • 项目类别:
Pharmacology and drug development
药理学和药物开发
  • 批准号:
    7235222
  • 财政年份:
    2006
  • 资助金额:
    $ 24.03万
  • 项目类别:
Scientific Core - Pharmacology and Drug Development
科学核心——药理学和药物开发
  • 批准号:
    9384948
  • 财政年份:
    2006
  • 资助金额:
    $ 24.03万
  • 项目类别:
CHEMICAL AND ENVIRONMENTAL EFFECTS ON MAMMALIAN SKIN
化学和环境对哺乳动物皮肤的影响
  • 批准号:
    7598517
  • 财政年份:
    2006
  • 资助金额:
    $ 24.03万
  • 项目类别:
Scientific Core - Pharmacology and Drug Development
科学核心——药理学和药物开发
  • 批准号:
    10490461
  • 财政年份:
    2006
  • 资助金额:
    $ 24.03万
  • 项目类别:
Scientific Core - Pharmacology and Drug Development
科学核心——药理学和药物开发
  • 批准号:
    10291224
  • 财政年份:
    2006
  • 资助金额:
    $ 24.03万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 24.03万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 24.03万
  • 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 24.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了